Clinical Trial Update: N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma [Phase 2]

View source ↗

Summary

This update covers a Phase 2 clinical trial testing reduced chemotherapy combined with monoclonal antibody–based therapy in children with neuroblastoma, which i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Chemotherapy regimen (reduced)
• Monoclonal antibody-based therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: High-risk Neuroblastoma, Neuroblastoma | Phase 2 | Status: RECRUITING